# US 8,277,781 B2 · Device for intranasal administration

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,277,781 B2
- Document ID: US8277781B2
- Status: Granted
- Kind: B2
- Application number: 12/404,250
- Filed: 2009-03-13
- Published: 2010-09-16
- Granted: 2012-10-02
- Earliest claimed: 2009-03-13
- Assignees: Luitpold Pharmaceuticals, Inc.
- Inventors: Roger Whiting; Ramachandran Thirucote
- Web page: https://patentgrep.com/patent/US8277781B2

## CPC

- A61M 11/007: {Syringe-type or piston-type sprayers or atomisers}
- A61K 9/0043: {Nose}
- A61K 31/407: condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
- A61M 15/08: Inhaling devices inserted into the nose
- A61P 25/06: Antimigraine agents
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61J 1/16: Holders for containers
- A61M 2209/06: Packaging for specific medical equipment
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61J: CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE

## Abstract

Disclosed herein are devices and processes for preparing a vial for an intranasal administration of a medicament where the vial comprises reduced oxygen content.

## Claims

### Claim 1

A method for reducing ketorolac degradation under ambient conditions wherein said ketorolac is in an aqueous composition maintained in an enclosed vial having a defined gaseous headspace and containing from about 12 to 38% w/v ketorolac wherein the method comprises:
a) placing said ketorolac vial on an assembly line;
b) moving the vial on said assembly line wherein the vial is exposed to a flow of an inert gas directly over and into the vial to purge at least a portion of the oxygen out of the vial and subsequently capping the vial, wherein the rate of the gas flow and capping process are adjusted such that the amount of oxygen remaining in the head space of the capped vial is about 5-10% v/v; and
c) capping the vial.

### Claim 2 (depends on 1)

The method of claim 1, wherein the inert gas is nitrogen.

### Claim 3 (depends on 1)

The method of claim 1, wherein the inert gas is a noble gas.

### Claim 4 (depends on 3)

The method of claim 3, wherein the inert gas is argon.

### Claim 5 (depends on 1)

The method of claim 1, wherein the ketorolac aqueous composition is preserved for at least 2 years at room temperature.

### Claim 6 (depends on 1)

The method of claim 1, wherein from about 100 to about 210 purged vials are capped per minute.
